Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an "Outpatient" Alemtuzumab and Fludarabine-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

Phuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, MD PhD, Emily McDuffee, Lisa Cook, Tatyana Worthy, Geri Hawks, Prince Patricia, Reem Shalabi, Brian Wells, Robert Reger, MS, Hanh Khuu, David Stroncek, Xin Tian, PhD, Nancy Geller, Georg Aue, Richard Childs, MD

Blood (2017) 130 (Supplement 1): 1962.

https://doi.org/10.1182/blood.V130.Suppl_1.1962.1962

Published: 2017

Journal Articles

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Sanaz Nicky Soltani, MD, Ramaprasad Srinivasan, MD, PhD, Theresa Jerussi, PAc, A. John Barrett, Thomas E Hughes, PharmD, BCOP, Catalina Ramos, RN, BSN, Lisa Cook, RN, BSN, Elena Cho, RN, MSN, Richard W. Childs, MD

Blood (2013) 122 (21): 4624.

https://doi.org/10.1182/blood.V122.21.4624.4624

Published: 2013

Journal Articles

Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT).

Elena Cherkasova, Elizabeth Malinzak, Sheila Rao, Vera N. Senchenko, Anna V. Kudryavtseva, Lev L. Kiselev, Yoshiyuki Takahashi, MD, PhD, Nanae Harashima, W. Marston Linehan, M.D, Ramaprasad Srinivasan, MD, PhD, Michael I. Lerman, Richard W. Childs, MD

Blood (2009) 114 (22): 467.

https://doi.org/10.1182/blood.V114.22.467.467

Published: 2009

Journal Articles

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display

Sivasubramanian Baskar, Jessica M. Suschak, Ivan Samija, Ramaprasad Srinivasan, Richard W. Childs, Steven Z. Pavletic, Michael R. Bishop, Christoph Rader

Blood (2009) 114 (20): 4494–4502.

https://doi.org/10.1182/blood-2009-05-222786

Published: 2009

Journal Articles

Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Ramaprasad Srinivasan, Haley Hedlin, Rose Goodwin, Aleah Smith, Catalina Ramos, Lisa Cook, Charles Bolan, Hisayuki Yokoyama, Shivani Srivastava, Jennifer Karpovich, Teresa Donohue, John Barrett, Nancy Geller, Richard Childs

Blood (2007) 110 (11): 2990.

https://doi.org/10.1182/blood.V110.11.2990.2990

Published: 2007

Journal Articles

Impact of KIR and HLA Genotypes on Outcome in Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Using HLA Matched Related Donors.

Ramaprasad Srinivasan, MD, PhD, Mary Carrington, Ph.D., Dante Suffredini, M.S., Aleah Smith, Maureen Martin, Ph.D, Maria Berg, M.S., A. John Barrett, M.D., Shivani Srivastava, M.D, Andreas Lundqvist, Ph.D., Hisayuki Yokoyoma, M.D., Bipin N. Savani, M.D., Richard W. Childs, M.D.

Blood (2006) 108 (11): 323.

https://doi.org/10.1182/blood.V108.11.323.323

Published: 2006

Journal Articles

Pre-Transplant T-Cell Lymphopenia Accelerates Early Donor T-Cell and Myeloid Chimerism but Is Not Required for Full Donor Lymphohematopoietic Engraftment or To Prevent Graft Rejection Following Nonmyeloablative Hematopoietic Cell Transplantation (NST).

Shivani Srivastava, Bipin N. Savani, N. Geller, C. Carvallo, Ramaprasad Srinivasan, Y. Takahashi, A. Lundqvist, R. Kurlander, R. Goodwin, A. John Barrett, T. Fleisher, Richard W. Childs

Blood (2006) 108 (11): 2981.

https://doi.org/10.1182/blood.V108.11.2981.2981

Published: 2006

Journal Articles

Adoptive Infusion of Allogeneic KIR Ligand Mismatched NK Cells Reduce GVHD in an MHC Matched Allogeneic Stem Cell Transplantation Model.

Andreas Lundqvist, PhD, Leigh Samsel, Michael Eckhaus, Ramaprasad Srinivasan, MD, PhD, Yoshiyuki Takahashi, MD, PhD, Maarten Snoeijs, MD, Philip J. McCoy, Jr., PhD, Maria Berg, Richard Childs, MD

Blood (2005) 106 (11): 1310.

https://doi.org/10.1182/blood.V106.11.1310.1310

Published: 2005

Journal Articles

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

Bipin N. Savani, MD, Ramaprasad Srinivasan, MD, PhD, Aldemar Montero, MD, Anurag Singh, MD, Aarthi Shenoy, MD, Shervin Kamipour, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1116.

https://doi.org/10.1182/blood.V106.11.1116.1116

Published: 2005

Journal Articles

High Response Rates in Acute Steroid Refractory Graft-Versus-Host Disease (GVHD) Following Combined Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-2 (IL-2) Blockade.

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Colleen Dorrance, MD, Igor Espinoza-Delgado, MD, A. John Barrett, MD, Yoshiyuki Takahashi, MD, PhD, Richard W. Childs, MD

Blood (2005) 106 (11): 1801.

https://doi.org/10.1182/blood.V106.11.1801.1801

Published: 2005

Journal Articles

Potent Graft-Versus-Renal Cell Carcinoma (RCC) Effects in a Murine Minor Histocompatibility Antigen (mHa)-Mismatched Allogeneic Transplant Model.

Andreas Lundqvist, PhD, Ramaprasad Srinivasan, MD, PhD, Dante Suffredini, BS, Yoshiyuki Takahashi, MD, PhD, Jason Wynberg, MD, Takehito Igarashi, MD, PhD, Amy Reese, MD, Warren Shlomchik, MD, Richard Childs, MD

Blood (2004) 104 (11): 4982.

https://doi.org/10.1182/blood.V104.11.4982.4982

Published: 2004

Journal Articles

Cd8+ T-Cells Specifically Cytotoxic to Renal Cell Carcinoma (RCC) Cells Can Be Isolated from Patients with Regressing Metastatic Kidney Cancer after Allogeneic Nonmyeloablative Hematopoietic Cell Transplantation (NMHCT).

Yoshiyuki Takahashi, MD, PhD, Othon Mena, MD, Ramaprasad Srinivasan, MD, PhD, Takehito Igarashi, MD, PhD, Andreas Lundqvist, PhD, Dante Suffredini, J. Philip McCoy, Jr, PhD, Ken-ichi Hanada, MD, PhD, Marston Linehan, MD, Richard Childs, MD

Blood (2004) 104 (11): 4984.

https://doi.org/10.1182/blood.V104.11.4984.4984

Published: 2004

Journal Articles

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Sakti Chakrabarti, MD, Igor Espinoza-Delgado, MD, Teresa Donohue, Susan Leitman, MD, Charles D. Bolan, MD, Elizabeth J. Read, MD, John A. Barrett, MD, Richard W. Childs, MD

Blood (2004) 104 (11): 1236.

https://doi.org/10.1182/blood.V104.11.1236.1236

Published: 2004

Journal Articles

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation

Yoshiyuki Takahashi, J. Philip McCoy, Jr, Cristian Carvallo, Candido Rivera, Takehito Igarashi, Ramaprasad Srinivasan, Neal S. Young, Richard W. Childs

Blood (2004) 103 (4): 1383–1390.

https://doi.org/10.1182/blood-2003-04-1281

Published: 2004

Journal Articles

Prior chemotherapy and allograft CD34 + dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors

Cristian Carvallo, Nancy Geller, Roger Kurlander, Ramaprasad Srinivasan, Othon Mena, Takehito Igarashi, Linda M. Griffith, W. Marston Linehan, Richard W. Childs

Blood (2004) 103 (4): 1560–1563.

https://doi.org/10.1182/blood-2003-04-1170

Published: 2004

NARROW

Durable Remission of Refractory and Advanced Stage Mycosis Fungoides/Sezary Syndrome (MF/SS) Utilizing an "Outpatient" Alemtuzumab and Fludarabine-Based Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT)

Long-Term Survival In Patients With Acute Steroid Refractory Graft-Versus-Host-Disease (SR-GVHD) Treated With Infliximab Combined With Daclizumab

Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT).

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display

Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Impact of KIR and HLA Genotypes on Outcome in Nonmyeloablative Hematopoietic Cell Transplantation (HCT) Using HLA Matched Related Donors.

Pre-Transplant T-Cell Lymphopenia Accelerates Early Donor T-Cell and Myeloid Chimerism but Is Not Required for Full Donor Lymphohematopoietic Engraftment or To Prevent Graft Rejection Following Nonmyeloablative Hematopoietic Cell Transplantation (NST).

Adoptive Infusion of Allogeneic KIR Ligand Mismatched NK Cells Reduce GVHD in an MHC Matched Allogeneic Stem Cell Transplantation Model.

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

High Response Rates in Acute Steroid Refractory Graft-Versus-Host Disease (GVHD) Following Combined Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-2 (IL-2) Blockade.

Potent Graft-Versus-Renal Cell Carcinoma (RCC) Effects in a Murine Minor Histocompatibility Antigen (mHa)-Mismatched Allogeneic Transplant Model.

Cd8+ T-Cells Specifically Cytotoxic to Renal Cell Carcinoma (RCC) Cells Can Be Isolated from Patients with Regressing Metastatic Kidney Cancer after Allogeneic Nonmyeloablative Hematopoietic Cell Transplantation (NMHCT).

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation

Prior chemotherapy and allograft CD34 + dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only